Mirtazapine treatment and sexual functions: Results of a Hungarian, multicentre, prospective study in depressed out-patients

P. Osváth, S. Fekete, Viktor Vörös, Janos Almási

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Since many antidepressants can cause sexual dysfunction, the aim of this study was to follow-up sexual functions during mirtazapine (RemeronSolTab®) treatment. One hundred and two (44 male and 58 female) outpatients with major depression were recruited to this prospective, observational, non-interventional study. The screening was followed by three visits, during which the 17-HAMD, CGI and 9-BDI scales were used. The change of sexual life was monitored by a self-completing questionnaire, based on the modified Psychotropic-Related Sexual Dysfunction Questionnaire. During the treatment both the depression rating scales and the CGI have shown a significant improvement and significant amelioration of previous sexual problems was found; patients were evaluating their sexual life better and better. Our results indicated that mirtazapine is an effective tool for depressed patients who suffer from sexual dysfunction.

Original languageEnglish
Pages (from-to)242-245
Number of pages4
JournalInternational Journal of Psychiatry in Clinical Practice
Volume11
Issue number3
DOIs
Publication statusPublished - 2007

Fingerprint

Multicenter Studies
Outpatients
Prospective Studies
Antidepressive Agents
Therapeutics
Surveys and Questionnaires
mirtazapine

Keywords

  • Depression
  • Mirtazapine (Remeron SolTab®)
  • Prospective study
  • Sexual dysfunction

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{3d7784069c924cf282a03acd6356730b,
title = "Mirtazapine treatment and sexual functions: Results of a Hungarian, multicentre, prospective study in depressed out-patients",
abstract = "Since many antidepressants can cause sexual dysfunction, the aim of this study was to follow-up sexual functions during mirtazapine (RemeronSolTab{\circledR}) treatment. One hundred and two (44 male and 58 female) outpatients with major depression were recruited to this prospective, observational, non-interventional study. The screening was followed by three visits, during which the 17-HAMD, CGI and 9-BDI scales were used. The change of sexual life was monitored by a self-completing questionnaire, based on the modified Psychotropic-Related Sexual Dysfunction Questionnaire. During the treatment both the depression rating scales and the CGI have shown a significant improvement and significant amelioration of previous sexual problems was found; patients were evaluating their sexual life better and better. Our results indicated that mirtazapine is an effective tool for depressed patients who suffer from sexual dysfunction.",
keywords = "Depression, Mirtazapine (Remeron SolTab{\circledR}), Prospective study, Sexual dysfunction",
author = "P. Osv{\'a}th and S. Fekete and Viktor V{\"o}r{\"o}s and Janos Alm{\'a}si",
year = "2007",
doi = "10.1080/13651500701241147",
language = "English",
volume = "11",
pages = "242--245",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Mirtazapine treatment and sexual functions

T2 - Results of a Hungarian, multicentre, prospective study in depressed out-patients

AU - Osváth, P.

AU - Fekete, S.

AU - Vörös, Viktor

AU - Almási, Janos

PY - 2007

Y1 - 2007

N2 - Since many antidepressants can cause sexual dysfunction, the aim of this study was to follow-up sexual functions during mirtazapine (RemeronSolTab®) treatment. One hundred and two (44 male and 58 female) outpatients with major depression were recruited to this prospective, observational, non-interventional study. The screening was followed by three visits, during which the 17-HAMD, CGI and 9-BDI scales were used. The change of sexual life was monitored by a self-completing questionnaire, based on the modified Psychotropic-Related Sexual Dysfunction Questionnaire. During the treatment both the depression rating scales and the CGI have shown a significant improvement and significant amelioration of previous sexual problems was found; patients were evaluating their sexual life better and better. Our results indicated that mirtazapine is an effective tool for depressed patients who suffer from sexual dysfunction.

AB - Since many antidepressants can cause sexual dysfunction, the aim of this study was to follow-up sexual functions during mirtazapine (RemeronSolTab®) treatment. One hundred and two (44 male and 58 female) outpatients with major depression were recruited to this prospective, observational, non-interventional study. The screening was followed by three visits, during which the 17-HAMD, CGI and 9-BDI scales were used. The change of sexual life was monitored by a self-completing questionnaire, based on the modified Psychotropic-Related Sexual Dysfunction Questionnaire. During the treatment both the depression rating scales and the CGI have shown a significant improvement and significant amelioration of previous sexual problems was found; patients were evaluating their sexual life better and better. Our results indicated that mirtazapine is an effective tool for depressed patients who suffer from sexual dysfunction.

KW - Depression

KW - Mirtazapine (Remeron SolTab®)

KW - Prospective study

KW - Sexual dysfunction

UR - http://www.scopus.com/inward/record.url?scp=34548853156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548853156&partnerID=8YFLogxK

U2 - 10.1080/13651500701241147

DO - 10.1080/13651500701241147

M3 - Article

AN - SCOPUS:34548853156

VL - 11

SP - 242

EP - 245

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 3

ER -